Evaluation of elevated urinary enolase I levels in patients with endometriosis

Diagnostic accuracy OA: green CC0 ⤵ 17 in-corpus citations
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

Urinary enolase I levels, corrected for creatinine, were significantly elevated in endometriosis patients, suggesting its potential as a biomarker when combined with serum CA-125.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-08 · read from full text ⓘ

This case-control study evaluated urinary enolase I as a potential biomarker in 39 women with histologically confirmed endometriosis versus 20 women without endometriosis, using western blot and enzyme-linked immunosorbent assay. The urinary non-neuronal enolase (NNE)-creatinine ratio was significantly higher in endometriosis patients, and combining NNE-Cr with serum CA-125 yielded an area under the ROC curve of 0.821, with reported sensitivity and specificity of 76.9% and 85.0%, respectively. A key limitation is the relatively small sample size and lack of discussion of broader external validation in the provided text. This paper is centrally about endometriosis — it tests and validates elevated urinary enolase I (NNE-Cr) alone and combined with CA-125 for diagnostic performance.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

OBJECTIVE: The aim of this study is to validate and investigate the clinical value of urinary enolase I in patients with endometriosis. METHODS: Urine samples of 39 patients with histologically confirmed endometriosis and 20 patients without endometriosis were collected. Western blot analysis and enzyme-linked immunosorbent assay were used to detect the increase of enolase I in patients' urine. RESULTS: Urinary enolase I expression corrected for creatinine ratio (non neuronal enolase (NNE)-Cr) was significantly greater in patients with endometriosis (p = 0.026). When the diagnostic performance of NNE-Cr was evaluated with serum CA-125 combination, the area under the curve was 0.821 (95% confidence interval 0.713-0.928) with sensitivity and specificity of 76.9% and 85.0%, respectively. CONCLUSION: Elevated urinary enolase I, in conjunction with serum CA-125, may be used as a potential biomarker for endometriosis.
Full text 2,471 characters · extracted from oa-html · 3 sections · click to expand

Methods

Urine samples of 39 patients with histologically confirmed endometriosis and 20 patients without endometriosis were collected. Western blot analysis and enzyme-linked immunosorbent assay were used to detect the increase of enolase I in patients' urine.

Results

Urinary enolase I expression corrected for creatinine ratio (non neuronal enolase (NNE)-Cr) was significantly greater in patients with endometriosis (p = 0.026). When the diagnostic performance of NNE-Cr was evaluated with serum CA-125 combination, the area under the curve was 0.821 (95% confidence interval 0.713-0.928) with sensitivity and specificity of 76.9% and 85.0%, respectively.

Conclusion

Elevated urinary enolase I, in conjunction with serum CA-125, may be used as a potential biomarker for endometriosis. - Appears in Collections: - 1. College of Medicine (의과대학) > Dept. of Obstetrics and Gynecology (산부인과학교실) > 1. Journal Papers 1. College of Medicine (의과대학) > Yonsei Biomedical Research Center (연세의생명연구원) > 1. Journal Papers - Yonsei Authors - Kim, Hye Yeon(김혜연) Park, Joo Hyun(박주현) Seo, Seok Kyo(서석교) https://orcid.org/0000-0003-3404-0484 Yun, Bo Hyon(윤보현) https://orcid.org/0000-0001-5703-797X Lee, Byung Seok(이병석) https://orcid.org/0000-0001-6001-2079 Yim, Su Youn(임수연) Chon, Seung Joo(전승주) Cho, Si Hyun(조시현) https://orcid.org/0000-0003-2718-6645 Choi, Young Sik(최영식) https://orcid.org/0000-0002-1157-4822 Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Biomarkers, Tumor DNA-Binding Proteins Endometriosis Phosphopyruvate Hydratase Tumor Suppressor Proteins Adult Adult Biomarkers Biomarkers Biomarkers Biomarkers, Tumor Biomarkers, Tumor CA-125 Antigen CA-125 Antigen CA-125 Antigen Case-Control Studies Case-Control Studies Creatinine Creatinine Creatinine

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (41)

Cited by (18)

Source provenance

europepmc
last seen: 2026-11-18T06:10:28.346261+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:12:56.342978+00:00
License: CC0 · commercial use OK